دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Spotlight on aortic stenosis and dissection: mechanisms, management, and new therapeutic targets
Filippo Crea
doi : 10.1093/eurheartj/ehad107
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 783–787
Patient study highlights the need to talk about INOCA
Judith Ozkan
doi : 10.1093/eurheartj/ehac828
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 788–789
The ‘Magic of Cardiology’
Stephan Achenbach
doi : 10.1093/eurheartj/ehad025
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 790–791
The ‘Ten Commandments’ of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Stephan Rosenkranz, Marion Delcroix, George Giannakoulas, Marius M Hoeper, Gabor Kovacs, Marc Humbert
doi : 10.1093/eurheartj/ehad018
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 792–793
Influenza vaccine for heart failure patients in low- and middle-income countries: another piece in the puzzle
Daniela Pedicino, Massimo Volpe
doi : 10.1093/eurheartj/ehac809
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 794–795
ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis
Grace Lee, Joanna Chikwe, Milan Milojevic, Harindra C Wijeysundera, Giuseppe Biondi-Zoccai, Marcus Flather, Mario F L Gaudino, Stephen E Fremes, Derrick Y Tam
doi : 10.1093/eurheartj/ehac803
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 796–812
Aortic stenosis (AS) is a serious and complex condition, for which optimal management continues to evolve rapidly. An understanding of current clinical practice guidelines is critical to effective patient care and shared decision-making.
Acute aortic dissection: evidence, uncertainties, and future therapies
Bartosz Rylski, Oliver Schilling, Martin Czerny
doi : 10.1093/eurheartj/ehac757
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 813–821
Remarkable progress has become especially apparent in aortic medicine in the last few decades, leading to essential changes in how thoracic aortic dissection is understood and treated.
Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitation
Andrea Scotti, Augustin Coisne, Maurizio Taramasso, Juan F Granada, Sebastian Ludwig, Josep Rodés-Cabau, Philipp Lurz, Jörg Hausleiter, Neil Fam, Susheel K Kodali, Joel Rosiene, Ari Feinberg, Alberto Pozzoli, Hannes Alessandrini, Luigi Biasco, Eric Brochet, Paolo Denti, Rodrigo Estévez-Loureiro, Christian Frerker, Edwin C Ho, Vanessa Monivas, Georg Nickenig, Fabien Praz, Rishi Puri, Horst Sievert, Gilbert H L Tang, Martin Andreas, Ralph Stephan Von Bardeleben, Karl-Philipp Rommel, Guillem Muntané-Carol, Mara Gavazzoni, Daniel Braun, Benedikt Koell, Daniel Kalbacher, Kim A Connelly, Jean-Michel Juliard, Claudia Harr, Giovanni Pedrazzini, Giulio Russo, François Philippon, Joachim Schofer, Holger Thiele, Matthias Unterhuber, Dominique Himbert, Marina Ureña Alcázar, Mirjam G Wild, Stephan Windecker, Ulrich Jorde, Francesco Maisano, Martin B Leon, Rebecca T Hahn, Azeem Latib
doi : 10.1093/eurheartj/ehac735
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 822–832
The impact of sexuality in patients with significant tricuspid regurgitation (TR) undergoing transcatheter tricuspid valve intervention (TTVI) is unknown. The aim of this study was to investigate sex-specific outcomes in patients with significant TR treated with TTVI vs. medical therapy alone.
Valvular heart diseases in women: facts vs. incantations
Maurice Enriquez-Sarano, Julia Grapsa
doi : 10.1093/eurheartj/ehac774
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 833–835
Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials
Yousif Ahmad, James P Howard, Ahran D Arnold, Mahesh V Madhavan, Christopher M Cook, Maria Alu, Michael J Mack, Michael J Reardon, Vinod H Thourani, Samir Kapadia, Hans Gustav Hørsted Thyregod, Lars Sondergaard, Troels Højsgaard Jørgensen, William D Toff, Nicolas M Van Mieghem, Raj R Makkar, John K Forrest, Martin B Leon
doi : 10.1093/eurheartj/ehac642
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 836–852
Additional randomized clinical trial (RCT) data comparing transcatheter aortic valve implantation (TAVI) with surgical aortic valve replacement (SAVR) is available, including longer term follow-up. A meta-analysis comparing TAVI to SAVR was performed. A pragmatic risk classification was applied, partitioning lower-risk and higher-risk patients.
Transcatheter aortic valve implantation: a blueprint for evidence-based evaluation of technological innovation
Thomas Pilgrim, George C M Siontis, Stephan Windecker
doi : 10.1093/eurheartj/ehac635
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 853–855
Transfemoral aortic valve implantation: procedural hospital volume and mortality in Germany
Kurt Bestehorn, Maike Bestehorn, Ralf Zahn, Christian Perings, Christoph Stellbrink, Volker Schächinger
doi : 10.1093/eurheartj/ehac698
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 856–867
Studies assessing transfemoral transcatheter aortic valve implantation (TF-TAVI) showed lower rates of in-hospital mortality at high-volume hospitals and minimum caseloads were recommended to assure quality standards.
Are contemporary TAVI results influenced by hospital volume?
Josep Rodés-Cabau, Jorge Nuche
doi : 10.1093/eurheartj/ehac694
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 868–870
Factors influencing post-surgical survival in degenerative mitral regurgitation
Steele C Butcher, Benjamin Essayagh, Ewout W Steyerberg, Giovanni Benfari, Clemence Antoine, Francesco Grigioni, Thierry Le Tourneau, Jean-Christian Roussel, Aniek van Wijngaarden, Nina Ajmone Marsan, Christophe Tribouilloy, Dan Rusinaru, Aviram Hochstadt, Yan Topilsky, Hector I Michelena, Victoria Delgado, Jeroen J Bax, Maurice Enriquez-Sarano
doi : 10.1093/eurheartj/ehad004
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 871–881
Indications for surgery in patients with degenerative mitral regurgitation (DMR) are increasingly liberal in all clinical guidelines but the role of secondary outcome determinants (left atrial volume index ≥60 mL/m2, atrial fibrillation, pulmonary artery systolic pressure ≥50 mmHg and moderate to severe tricuspid regurgitation) and their impact on post-operative outcome remain disputed.
Advances in risk stratification of asymptomatic mitral regurgitation. The quest for optimal timing of surgery continues
Bernard Iung, Gaspard Suc
doi : 10.1093/eurheartj/ehad040
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 882–884
Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity
Farwah Iqbal, Florian Schlotter, Dakota Becker-Greene, Adrien Lupieri, Claudia Goettsch, Joshua D Hutcheson, Maximillian A Rogers, Shinsuke Itoh, Arda Halu, Lang Ho Lee, Mark C Blaser, Andrew K Mlynarchik, Sumihiko Hagita, Shiori Kuraoka, Hao Yu Chen, James C Engert, Livia S A Passos, Prabhash K Jha, Eric A Osborn, Farouc A Jaffer, Simon C Body, Simon C Robson, George Thanassoulis, Masanori Aikawa, Sasha A Singh, Abhijeet R Sonawane, Elena Aikawa
doi : 10.1093/eurheartj/ehac818
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 885–898
Calcific aortic valve disease (CAVD) is the most common valve disease, which consists of a chronic interplay of inflammation, fibrosis, and calcification. In this study, sortilin (SORT1) was identified as a novel key player in the pathophysiology of CAVD, and its role in the transformation of valvular interstitial cells (VICs) into pathological phenotypes is explored.
Have we found the missing link between inflammation, fibrosis, and calcification in calcific aortic valve disease?
Marcy Martin, Sarah E Motta, Maximilian Y Emmert
doi : 10.1093/eurheartj/ehac787
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Pages 899–901
Pathologic findings of aortic valve leaflet injury via IMPELLA insertion
Toru Miyoshi, Hironori Izutani, Osamu Yamaguchi
doi : 10.1093/eurheartj/ehac806
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Page 902
Emergent transcatheter aortic valve implantation combined with enterectomy for acute decompensated heart failure caused by severe aortic stenosis and strangulated femoral hernia
Tao Zhang, Xinfeng Yang, Jiaguang Song, Yulong Shi, Zhengjun Wang
doi : 10.1093/eurheartj/ehad007
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Page 903
One stone hits two birds: transcatheter mitral valve edge-to-edge repair for hypertrophic obstructive cardiomyopathy and severe mitral regurgitation
Xinyi Huang, Shih-Hsien Sung, Maolong Su, Yan Wang
doi : 10.1093/eurheartj/ehac677
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Page 904
Corrigendum to: The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias
doi : 10.1093/eurheartj/ehad023
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Page 852
Corrigendum to: Preprints: a game changer in scientific publications?
doi : 10.1093/eurheartj/ehad024
European Heart Journal, Volume 44, Issue 10, 7 March 2023, Page 870
